loader
Please Wait
Applying Filters...

Annual Sales of NCGC00024708-02 reported using PharmaCompass' compilation of Annual Reports of Global Pharmaceutical Companies.

Menu
$ API Ref.Price (USD/KG) : 1,007Xls
Filters Filter
Cross PopUp
FILTER :

filter clear-filterReset all filters

01 2Thalomid

02 3Thalomid

PharmaCompass

01

Brand Name : Thalomid

Thalidomide

arrow
Formnext Forum
Not Confirmed

Brand Name : Thalomid

arrow
Formnext Forum
Not Confirmed

Thalidomide

Main Therapeutic Indication : Skin Disorder

Currency : USD

2015 Revenue in Millions : 221

2014 Revenue in Millions : 185

Growth (%) : -16%

blank

02

Brand Name : Thalomid

Thalidomide

arrow
Formnext Forum
Not Confirmed

Brand Name : Thalomid

arrow
Formnext Forum
Not Confirmed

Thalidomide

Main Therapeutic Indication : Oncology

Currency : USD

2017 Revenue in Millions : 132

2016 Revenue in Millions : 152

Growth (%) : -13

blank

03

Brand Name : Thalomid

Thalidomide

arrow
Formnext Forum
Not Confirmed

Brand Name : Thalomid

arrow
Formnext Forum
Not Confirmed

Thalidomide

Main Therapeutic Indication : Oncology

Currency : USD

2016 Revenue in Millions : 152

2015 Revenue in Millions : 185

Growth (%) : -18

blank

04

Brand Name : Thalomid

Thalidomide

arrow
Formnext Forum
Not Confirmed

Brand Name : Thalomid

arrow
Formnext Forum
Not Confirmed

Thalidomide

Main Therapeutic Indication : Oncology

Currency : USD

2018 Revenue in Millions : 114

2017 Revenue in Millions : 132

Growth (%) : -14%

blank

05

Brand Name : Thalomid

Thalidomide

arrow
Formnext Forum
Not Confirmed